Overview
During MeTHOS study will be collected Real World Data the clinical practice regarding Thromboprophylaxis in high thrombotic risk solid tumors patients undergoing surgical and /or chemotherapeutical treatment, for one year following the protocol initiation date.
Specifically focus will be on the following:
- Number of thrombotic events
- Anti-thrombotic management dosage & duration
- Any bleedings related to anticoagulation
- Patients' adherence and compliance
Eligibility
Inclusion Criteria:
- Patients who were diagnosed with histological confirmed high thrombotic risk cancers (GI, thoracic, gynecologic and genitourinary) undergoing surgery
- Age 18 years
- Eastern Cooperative Oncology Group (ECOG) performance status 0-2
- Life expectancy >6 months
- Signed informed consent
Exclusion Criteria
- Patients who were not diagnosed with histological confirmed high thrombotic risk cancers (GI, thoracic, gynecologic and genitourinary) undergoing surgery
- Age < 18 years
- ECOG performance status >2
- Life expectancy <6 months
- Not signed informed consent